Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Schedules Call, Will Release Q4 and FY 2020 Financial Results

Trxade Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will report Q4 and FY 2020 financial results. MEDS will release the numbers, which are for the fourth quarter and fiscal year ended Dec. 31, 2020, after market close on March 29, 2021. As part of the reporting strategy, MEDS management will host a conference call. The call is scheduled for 5 p.m. ET on Monday, March 29, 2021. During the scheduled event, Trxade Group execs will discuss the company’s financial results and business highlights. The call will end with ample time for participants to ask MEDS team leaders clarifying and follow-up questions. Individuals interested in participating in the conference call or webcast can do so by dialing 1-877-425-9470 in the United States; international callers can dial 1-201-389-0878. Those who desire to call in are invited to call in at least 10 minutes early. In addition, a playback of the call can be accessed by phone — call 1-844-512-2921 inside the U.S. or 1-412-317-6671 when calling internationally and enter replay pin number 13716956 — or in the IR section of the company’s website.

To register for the webcast, visit https://ibn.fm/ZxHol

To view the full press release, visit https://ibn.fm/cCFhJ

About Trxade Group Inc.

Trxade Group is a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving a total of 11,800-plus members nationwide and fostering price transparency as well as the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

This entry was posted in Trxade Group Inc. (MEDS). Bookmark the permalink.

Comments are closed.